Novotech Featured Reports

  1. Designing A Global Drug Development Program To Secure FDA Approval 2/7/2023

    Global clinical trials in the Asia-Pacific region are becoming an attractive solution for young biotech companies looking to utilize their capital efficiently and secure high-quality clinical data quickly.

  2. Leveraging Global Drug Development Programs To Ensure Trial Success 2/7/2023

    Opting to take your biotech program global can help save crucial resources, produce high-quality clinical data for your therapy, and leverage unique regional advantages like region-specific indication strategies.

  3. COVID-19: Asia Pacific Clinical Trial Landscape 9/29/2022

    In December 2019, a novel coronavirus was discovered in China causing severe acute respiratory syndrome-like pneumonia which resulted in a pandemic. Find out more details regarding its spread in this report.

  4. Solid Tumors: Asia Pacific Clinical Trial Landscape 9/29/2022

    Read more about how the large population and lower volume of studies decreases competing trial risk in this region with a great need for novel drug therapies for solid tumors in Asian patients